Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Accumulated Expenses (2016 - 2025)

Firefly Neuroscience has reported Accumulated Expenses over the past 15 years, most recently at $766000.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $766000.0 for Q4 2025, down 52.89% from a year ago — trailing twelve months through Dec 2025 was $766000.0 (down 52.89% YoY), and the annual figure for FY2025 was $766000.0, down 52.89%.
  • Accumulated Expenses for Q4 2025 was $766000.0 at Firefly Neuroscience, up from $658000.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for AIFF hit a ceiling of $1.9 million in Q4 2023 and a floor of $2666.0 in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $541777.0 (2024), compared with a mean of $611216.2.
  • Peak annual rise in Accumulated Expenses hit 29165.71% in 2021, while the deepest fall reached 97.87% in 2021.
  • Firefly Neuroscience's Accumulated Expenses stood at $524055.0 in 2021, then crashed by 76.14% to $125033.0 in 2022, then soared by 1421.2% to $1.9 million in 2023, then fell by 14.51% to $1.6 million in 2024, then crashed by 52.89% to $766000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $766000.0 (Q4 2025), $658000.0 (Q3 2025), and $532000.0 (Q2 2025) per Business Quant data.